Dualitas Therapeutics News and Activities

Acquisition, funding and merger involving Dualitas Therapeutics.

• Dualitas Therapeutics has just announced a $65 Million fundraising (posted on September 19 2025).

View the org chart displaying its 13 main executives

Most searched biographies at Dualitas Therapeutics

• Karim Dabbagh, Chief Executive Officer
• Rich Murray, Director
• Thomas Hudson, Director

Popular executive movements at Dualitas Therapeutics

• Karim Dabbagh has joined the company as Chief Executive Officer  (posted on June 8 2026).
• Ursula Jeffry has joined the company as Vice President, Nonclinical Development  (posted on March 23 2026).

Create your alert
to follow the executive moves at Dualitas Therapeutics.

Dualitas Therapeutics has 2,403 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Dualitas Therapeutics

Social media about Dualitas Therapeutics

• Dualitas Therapeutics on Wikipedia, Google News & Yahoo Finance
• Dualitas Therapeutics on LinkedIn, X (Twitter) & YouTube